Constellation announced a $26.6 billion deal in January to acquire Calpine and create the largest independent power producer ...

In simple terms, if you plan to buy and sell individual stocks through an online broker, you're planning to be an active investor. To successfully be an active investor, you'll need three things ...

If you're in the market to buy a house, don't expect mortgage rates to drop anytime soon. "In the near term, rates are going to be stuck near 7%," said Jonathan Miller, CEO of Miller Samuel Real ...

In a report released on March 7, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Codexis (CDXS – Research Report), with a ...

They can also be risky. Learn how to create, buy, and sell NFTs. NFTs have exploded in popularity during the pandemic, leading many investors to wonder how to buy them. Artists, collectors ...

Many people interested in trading stocks wonder if there are any rules about when to buy or sell stocks. While some vague timing guidelines do exist, the best time to buy or sell a stock really ...

When Is the New iPhone Coming Out? The iPhone 16 line launched in September 2024, which means the iPhone 17 likely won't arrive until September or October 2025. The most recent iPhone 16e arrived ...

There may be no better place to purchase one of the best TVs than Best Buy. There is almost always some huge savings to find on TVs at Best Buy, and that’s certainly the case right now.

The best blue-chip stocks to buy for 2025 are more like the tortoise and less like the hare. The following 10 picks all offer entrenched operations with massive market values of $35 billion or ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. I’ve been testing and reviewing the best TVs for nearly 30 years and have witnessed ...

CytomX Therapeutics (CTMX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

Shares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad multi-year manufacturing agreement with CordenPharma for both the oral and ...